Are Sleeping Pills Safe Long-Term? Risks to Know

What types of sleep medication are people most commonly using?

Sleep medications fall into several categories, each with a different risk profile:

• Benzodiazepine receptor agonists ("Z-drugs") — zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata). These are among the most prescribed and among the most concerning with long-term use.
• Benzodiazepines — older sedatives such as temazepam and triazolam, now used less frequently for insomnia but still prescribed.
• Orexin receptor antagonists — suvorexant (Belsomra), lemborexant (Dayvigo). Newer, and considered to have a somewhat different dependence profile.
• Low-dose antidepressants — doxepin (Silenor) at low doses, trazodone used off-label. Less abuse potential, but their own side effect considerations.
• OTC antihistamine-based aids — diphenhydramine (Benadryl, ZzzQuil, Unisom) and doxylamine. Widely available, but with real risks that many people underestimate.
• Melatonin — available OTC; evidence supports its use for circadian issues like jet lag 1Ref 1Herxheimer A, Petrie KJ (2002).Melatonin for the Prevention and Treatment of Jet Lag.Melatonin has established evidence for circadian-related sleep issues such as jet lag, less so for general insomnia disorder. but is more limited for general insomnia.

What are the risks of long-term use of prescription sleep medications?

The Z-drugs and benzodiazepines carry the most concern with extended use:

Tolerance and dependence. The brain adapts to these drugs over days to weeks of regular use, meaning the same dose becomes less effective. Stopping abruptly can produce rebound insomnia — often worse than the original sleep problem — and, in the case of benzodiazepines, potentially serious withdrawal effects that require medical management.

Next-day impairment. Many sleep medications produce sedation that extends into the following day, impairing driving, reaction time, and memory. The FDA has required black-box warnings about morning impairment for some Z-drugs.

Falls and fractures. In older adults, sedating medications significantly increase the risk of falls, which can have serious consequences. This is a particular concern for anyone over 65.

Cognitive effects. Some research has raised questions about associations between long-term benzodiazepine use and dementia risk, though the causal relationship remains under study.

Orexin antagonists appear to have a more favorable dependence profile, but they are newer, and evidence on very long-term use is still accumulating.

Are over-the-counter sleep aids safer?

Not necessarily. OTC antihistamine-based sleep aids (diphenhydramine, doxylamine) are widely perceived as gentle because they are sold without a prescription. In practice:

• Tolerance develops quickly — often within a few nights — making them ineffective for most people after a short time.
• They can cause significant next-day grogginess, confusion, and dry mouth.
• In older adults, they are associated with delirium, urinary retention, and increased fall risk.
• Regular use does not address the underlying cause of insomnia.

Melatonin is safer in this regard — it is not habit-forming and has an established role for circadian-related sleep issues — but it has not been shown in most studies to be an effective standalone treatment for general insomnia disorder.

What actually works for long-term sleep improvement?

The AASM clinical practice guideline on behavioral treatments for insomnia recommends CBT-I as the first-line treatment for chronic insomnia disorder — not medication 2Ref 2Edinger JD, Arnedt JT, Bertisch SM, et al. (2021).Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.CBT-I is the first-line recommended treatment for chronic insomnia, preferred over medication.. CBT-I is a structured program (typically 6 to 8 weeks) that addresses the thoughts and behaviors perpetuating poor sleep. A large meta-analysis confirmed its effectiveness, with benefits that persist long after treatment ends 3Ref 3Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D (2015).Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis.CBT-I produces meaningful, durable improvements in chronic insomnia with benefits persisting after treatment ends..

CBT-I encompasses: - Sleep restriction — initially counterintuitive, but highly effective at rebuilding sleep pressure - Stimulus control — re-associating the bed with sleep rather than wakefulness - Sleep hygiene — consistent timing, limiting caffeine late in the day 4Ref 4Drake C, Roehrs T, Shambroom J, Roth T (2013).Caffeine Effects on Sleep Taken 0, 3, or 6 Hours before Going to Bed.Caffeine up to 6 hours before bed significantly disrupts sleep — eliminating it is a core sleep hygiene step., reducing evening light exposure 5Ref 5Chang AM, Aeschbach D, Duffy JF, Czeisler CA (2015).Evening Use of Light-Emitting eReaders Negatively Affects Sleep, Circadian Timing, and Next-Morning Alertness.Evening screen light exposure suppresses melatonin and delays sleep onset — reducing it supports sleep hygiene. - Cognitive restructuring — addressing anxious or unhelpful thoughts about sleep

Digital and app-based CBT-I programs have shown effectiveness for people who cannot access in-person therapy. A Gale primary-care clinician can guide you toward appropriate programs or a referral.

When is medication appropriate?

Sleep medications have a role in short-term use — managing acute situational insomnia, helping someone get through a particularly difficult stretch, or as a bridge while beginning CBT-I. The key word is short-term. The decision to use a sleep medication, which one, at what dose, and for how long are questions for a clinician who knows your full health picture. Never stop a prescription sleep medication abruptly without guidance.